Page last updated: 2024-12-10

13,16-docosadienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 13,16-Docosadienoic acid (DD)

13,16-Docosadienoic acid (DD) is a **long-chain polyunsaturated fatty acid (PUFA)** with two double bonds located at the 13th and 16th carbon positions. It has a 22-carbon chain, making it a **docosanoic acid** derivative.

**Importance in Research:**

DD is a **relatively new research topic**, and its potential functions are still being explored. However, preliminary findings suggest several areas of significance:

* **Cancer:** DD has shown **anti-cancer properties** in various studies. It has been observed to:
* Inhibit cell proliferation and induce apoptosis in cancer cells
* Suppress tumor growth and metastasis
* Enhance the efficacy of chemotherapeutic drugs
* **Inflammation:** DD exhibits **anti-inflammatory effects** by:
* Suppressing the production of pro-inflammatory cytokines
* Reducing the activation of inflammatory pathways
* Promoting the resolution of inflammation
* **Neuroprotection:** DD has shown **neuroprotective potential** by:
* Protecting neurons from damage caused by oxidative stress
* Reducing neuronal apoptosis
* Enhancing cognitive function
* **Cardiovascular health:** Some studies suggest that DD may have beneficial effects on cardiovascular health by:
* Reducing blood pressure
* Improving lipid profiles
* Reducing the risk of atherosclerosis

**Sources and Availability:**

DD is naturally present in **small amounts** in various sources like:

* **Fish oil:** Certain types of fish oil, particularly from deep-sea fish, contain DD.
* **Plant oils:** Some plant oils, like flaxseed oil, contain small amounts of DD.

However, the availability of DD is limited, and it is **not commercially available** in high quantities.

**Current Research:**

Ongoing research focuses on:

* **Exploring the mechanisms underlying the biological effects of DD.**
* **Developing efficient methods for producing and extracting DD.**
* **Investigating the potential therapeutic applications of DD in various diseases.**

**Future Prospects:**

DD holds **promise as a potential therapeutic agent** for a range of conditions, including cancer, inflammation, neurological disorders, and cardiovascular diseases. Further research is necessary to fully understand its mechanisms of action and safety profile before it can be used clinically.

**Note:** The research on 13,16-docosadienoic acid is still ongoing and there is limited clinical evidence to support its potential therapeutic benefits.

13,16-docosadienoic acid: RN refers to (Z,Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5282807
CHEBI ID145970
SCHEMBL ID466012
MeSH IDM0210159

Synonyms (14)

Synonym
LMFA01030132
13,16-docosadienoic acid
CHEBI:145970
(13e,16e)-docosa-13,16-dienoic acid
13,16-da
13,16-cis,cis-docosadienoic acid
13-cis,16-cis-docosadienoic acid
7370-49-2
SCHEMBL466012
13,16-docosadienoic acid, (13e,16e)-
(13e,16e)-13,16-docosadienoic acid
624722-08-3
NEL3BFU3S4
DTXSID001009342
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
very long-chain fatty acidA fatty acid which has a chain length greater than C22. Very long-chain fatty acids which have a chain length greater than C27 are also known as ultra-long-chain fatty acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Omega-3 and omega-6 unsaturated fatty acids biosynthesis pathway014

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.98 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]